Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Experts don't fully agree on how to diagnose certain hair growth disorders and more research is needed to understand them better.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Some alternative therapies for vitiligo show promise but need more research.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Cynomorium songaricum has many health benefits and could help with hair regrowth.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Hair loss improved with treatment and successful transplant.

Pregnancy can cause various skin changes and diseases, requiring careful treatment to protect the baby.

Hair follicle systems are being engineered to better mimic natural hair follicles for studying hair disorders and testing treatments.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

FFA has higher long-term remission rates than LPP.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Celiac patients may have kidney function risks due to increased urea and creatinine and decreased magnesium, zinc, and vitamin C.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.